Skylight Health Graduates to OTCQX® Market in the United States

• Skylight Health graduates to the highest tier of the OTC Markets offering greater visibility for the Company’s shares and improved liquidity
• Company will continue trading under U.S. ticker symbol (CBIIF) as the company works to update the ticker to align with Canadian Securities Exchange ticker SHG
• The Company remains DTC eligible to help provider investors easy access and liquidity in all jurisdictions

TORONTO, Dec. 02, 2020 (GLOBE NEWSWIRE) — Skylight Health Group Inc. (formerly CB2 Insights) (CSE:SHG; OTCQX: CBIIF) (“Skylight Health” or the “Company”), one of the largest multi-specialty healthcare services in the United States, is pleased to announce that its common shares are now trading on the OTCQX® Market under the symbol “CBIIF”, having graduated from the OTCQB® Venture Market.

The OTCQX Best Market is OTC Markets Group’s premier market for established, investor-focused U.S. and international companies. To be eligible, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with relevant U.S. securities laws, be current in their disclosure, and have an introduction from a professional third-party sponsor. Companies that are penny stocks, shells, or are in bankruptcy are excluded from trading on this tier. Skylight joins the top-tier OTC Market alongside names including Roche and Deutsche Telecom.

“Graduating to the OTCQX Market is yet another milestone achieved as we continue to execute our focused growth plan of becoming one of the largest US integrated healthcare systems,” said Prad Sekar, CEO of Skylight Health. “Having our shares traded on the top-tier of the OTC Markets in the US is a testament to Skylight’s successful transition from a venture company to a fast-growing US healthcare company. Graduating today to the OTCQX is a welcome progression offering our shareholders increased cross-border liquidity as well as further increasing our visibility and shareholder exposure in the United States.”

Skylight Health’s common shares continue to trade on the Canadian Securities Exchange under the symbol SHG.

About Skylight Health Group

Skylight Health Group (CSE:SHG OTCQB:CBIIF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state health network that comprises of physical multi-disciplinary medical clinics providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations. healthcare services. With a patient roster of over 120,000 patients, the Company’s operations spread across 14 states and continues to expand in services and locations both organically and by way of strategic acquisitions.

The Company primarily operates a traditional insurable fee-for-service model contracting with Medicare, Medicaid and other Commercial Payors. The Company also offers a disruptive subscription-based telemedicine service for the un/under-insured population who have limited access to urgent care due to cost.

For more information, please visit www.skylighthealthgroup.com or contact:

Investor Relations
Jonathan L. Robinson CFA
Oak Hill Financial
jrobinson@oakhillfinancial.ca
416-669-1001

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health’s filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements regarding the Company’s unaudited financial results and projected growth.

Although Skylight Health as attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are subject to inconsistent legislation and regulation; change in laws; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and recreational-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.

No securities regulator or exchange has reviewed, approved, disapproved, or accepts responsibility for the content of this news release.